News

Vaccine slashes odds of flu hospitalizations for older adults


 

AT ID WEEK 2014

References

PHILADELPHIA – Receiving a flu shot cut the odds of influenza hospitalizations by 56% among older adults during the 2010-2011 flu season, surveillance data show.

Vaccine effectiveness was consistent across all age groups, even among those aged 75 years or older.

Dr. Fiona Havers

Dr. Fiona Havers

“Continued emphasis on the importance of influenza vaccination among older adults is crucial,” Dr. Fiona Havers said at an annual scientific meeting on infectious diseases.

She reported on 364 adults, aged 50 years and older, who received a flu shot at least 14 days prior to hospital admission for laboratory-confirmed influenza during the 2010-2011 season. Cases were admitted to one of 11 sites participating in the Emerging Infections Program, now FluSurv-Net, and were matched by age and county to 773 controls.

Cases were significantly more likely than were controls to be of nonwhite race (31% vs. 15%), to be Hispanic (7% vs. 2%), to have an annual income less than $35,000 (52% vs. 33%), to have high school or lower-level education (44% vs. 27%), and to have at least two chronic health conditions (72% vs. 36%) (P values < .01 for all).

Estimates of influenza vaccine effectiveness in preventing hospitalization was 33% for all ages, 33% for ages 50-64 years, 45% for ages 65-74 years, and 21% for those 75 years and older, reported Dr. Havers of the influenza division of the Centers for Disease Control and Prevention in Atlanta.

After adjustment for age, gender, race/ethnicity, income, education, recent hospitalization, functional status, and chronic medical conditions, vaccine effectiveness estimates were 56%, 64%, 61%, and 57%, respectively, (P values < .05 for all).

The investigators also looked at influenza subtype and found that after adjustment, vaccination was associated with a significant reduction in the risk of hospitalizations for influenza A H3N2 (51%) and influenza B (95%), but not influenza A H1N1 (46%), likely because of the small number of H1N1 cases, said Dr. Havers, who urged older adults to seek care if they develop symptoms, even if they were vaccinated.

“We know that antiviral treatment is recommended for all older adults with suspected influenza, as they are at high risk for influenza complications, and antiviral drugs work best if given promptly after symptoms develop,” she said in an interview. ID Week comprises the combined annual meetings of the Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, HIV Medicine Association, and Pediatric Infectious Diseases Society.

pwendling@frontlinemedcom.com

Recommended Reading

Nintedanib, pirfenidone approved for pulmonary fibrosis
MDedge Internal Medicine
FDA panel supports retaining Chantix boxed warning for now
MDedge Internal Medicine
Biomarkers identify RA patients at risk of lung disease
MDedge Internal Medicine
Clinical Guidelines: Obstructive sleep apnea
MDedge Internal Medicine
FDA panel supports retaining Chantix boxed warning for now
MDedge Internal Medicine
Short-course TB therapy fails in three international trials
MDedge Internal Medicine
Post-PCV13 findings prompt continued surveillance
MDedge Internal Medicine
LAMA/LABA combo tops fluticasone/salmeterol in moderate/severe COPD
MDedge Internal Medicine
Pneumonia-related readmissions plummeted under QI initiative
MDedge Internal Medicine
Comborbidities likely explain opioid + sleep apnea mortality risk
MDedge Internal Medicine